The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Tanya Jindal
No Relationships to Disclose
 
Cindy Jiang
No Relationships to Disclose
 
Elise Cai
No Relationships to Disclose
 
Jeffrey Zhong
No Relationships to Disclose
 
Eugene Oh
No Relationships to Disclose
 
Salvador Casas
No Relationships to Disclose
 
Dimitra Bakaloudi
No Relationships to Disclose
 
Hamid Emamekhoo
Consulting or Advisory Role - Bristol Myers Squibb company; Cardinal Health; Eisai
 
Yousef Zakharia
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Eisai; EMD Serono; Exelixis; Genzyme; Gilead Sciences; Janssen; Novartis; Pfizer
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Amanda Nizam
Honoraria - Aptitude Health; ASCO; Cleveland Clinic; Doximity; IntegrityCE; Mashup Media (GU Oncology Now); MECC Global Meetings; SignifyMD; Targeted Oncology
Consulting or Advisory Role - Astellas Pharma; AVEO; EMD Serono/Merck; IDEOlogy Health; Mashup Media (GU Oncology Now); Pfizer/Seagen
Travel, Accommodations, Expenses - ASCO; Mashup Media; MECC Global Meetings
 
Matthew Milowsky
Stock and Other Ownership Interests - Gilead Sciences; Pfizer
Research Funding - Acrivon Therapeutics (Inst); Alliance for Clinical Trials in Oncology (Inst); ALX Oncology (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Flare Therapeutics (Inst); G1 Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); OncoC4 (Inst); PCCTC (Inst); Pfizer (Inst); Roche (Inst)
Other Relationship - Elsevier; OncLive/MJH Life Sciences; Prime Education; Research to Practice
(OPTIONAL) Uncompensated Relationships - G1 Therapeutics; Loxo/Lilly
 
Sumit Shah
Consulting or Advisory Role - Grand Rounds/Included Health; Janssen; Pacific Business Group on Health
Research Funding - Genentech
 
Arnab Basu
Honoraria - Cardinal Health; Eisai; Gilead Sciences; Natera
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/UCB Japan (I); EMD Serono; Seagen
Research Funding - Astellas Pharma (Inst); AVEO (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Merck (Inst); Natera (Inst)
 
Petros Grivas
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Foundation Medicine; Gilead Sciences; Janssen; Lilly; Merck; Pfizer; Replimune; Roche; Strata Oncology; Tyra Biosciences; Urogen pharma
Research Funding - Acrivon Therapeutics (Inst); ALX Oncology (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Abhishek Tripathi
Consulting or Advisory Role - Deka biosciences; Gilead Sciences; Pfizer; Systimmune
Speakers' Bureau - Janssen (I); Sanofi
 
Irene Tsung
No Relationships to Disclose
 
Jason Brown
Honoraria - Ipsen; Johnson & Johnson/Janssen
Consulting or Advisory Role - AstraZeneca; EMD Serono; Johnson & Johnson/Janssen; Pfizer
Speakers' Bureau - Merck
Research Funding - Bicycle Therapeutics (Inst); Indaptus Therapeutics; Merck (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Omar Alhalabi
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bicycle Therapeutics; Cardinal Health; Seagen; Silverback Therapeutics
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst)
 
Vadim Koshkin
Consulting or Advisory Role - Astellas Pharma; Bicycle Therapeutics; Bristol Myers Squibb Foundation; Janssen; Loxo; Merck; MSD; Natera; Pfizer; Roche/Genentech; Tempus
Research Funding - Curium Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pfizer/Astellas (Inst); Seagen (Inst); Taiho Oncology (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer